IsoPlexis to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO) will release its financial results for Q4 and the full year of 2021 on March 2, 2022, before market open. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET, accessible via the company’s website. The IsoPlexis platform aids researchers by identifying multifunctional single cells, advancing disease understanding, and is recognized for innovation in the field. Their systems are utilized by major pharmaceutical companies and leading cancer centers worldwide.

Positive

• IsoPlexis platform utilized by top 15 global pharmaceutical companies.
• Recognition for innovation from notable industry publications.

Negative

• None.

BRANFORD, Conn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the fourth quarter and full year 2021 before market open on Wednesday, March 2, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event.

About IsoPlexis
IsoPlexis is the Superhuman Cell company.

IsoPlexis’ systems uniquely identify a comprehensive range of multifunctional single cells, i.e. the superhero cells in the human body. These cells enable researchers to understand and predict disease progression, treatment resistance and therapeutic efficacy to advance all of human health.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at two-thirds of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com 

Press Contact
press@isoplexis.com

FAQ

What date will IsoPlexis report its Q4 2021 financial results?

IsoPlexis will report its Q4 2021 financial results on March 2, 2022.

What time is the IsoPlexis conference call scheduled for?

The IsoPlexis conference call is scheduled for 5:30 a.m. PT / 8:30 a.m. ET.

Where can I listen to the IsoPlexis earnings call?

The IsoPlexis earnings call can be accessed on their website in the 'Investors' section.

What is the significance of the IsoPlexis platform?

The IsoPlexis platform uniquely identifies multifunctional single cells to enhance disease research and therapeutic efficacy.